Published in Int J Cancer on May 20, 2005
Simultaneous amplification and identification of 25 human papillomavirus types with Templex technology. J Clin Microbiol (2006) 1.75
Human papillomavirus cofactors by disease progression and human papillomavirus types in the study to understand cervical cancer early endpoints and determinants. Cancer Epidemiol Biomarkers Prev (2009) 1.70
Relationship between cigarette smoking and human papilloma virus types 16 and 18 DNA load. Cancer Epidemiol Biomarkers Prev (2009) 1.18
DNA and RNA references for qRT-PCR assays in exfoliated cervical cells. J Mol Diagn (2006) 1.15
Serum antibodies to the HPV16 proteome as biomarkers for head and neck cancer. Br J Cancer (2011) 1.13
Viral load in the natural history of human papillomavirus type 16 infection: a nested case-control study. J Infect Dis (2011) 1.08
Sensitive and specific peak detection for SELDI-TOF mass spectrometry using a wavelet/neural-network based approach. PLoS One (2012) 1.06
Quantitative human papillomavirus 16 and 18 levels in incident infections and cervical lesion development. J Med Virol (2009) 1.06
Inverse association between methylation of human papillomavirus type 16 DNA and risk of cervical intraepithelial neoplasia grades 2 or 3. PLoS One (2011) 0.94
Gene expression profile of cervical tissue compared to exfoliated cells: impact on biomarker discovery. BMC Genomics (2005) 0.92
Effect of storage temperatures on the stability of cytokines in cervical mucous. Cytokine (2007) 0.91
Absolute quantitative real-time polymerase chain reaction for the measurement of human papillomavirus E7 mRNA in cervical cytobrush specimens. Infect Agent Cancer (2007) 0.90
E6 and E7 from human papillomavirus type 16 cooperate to target the PDZ protein Na/H exchange regulatory factor 1. J Virol (2011) 0.90
Kinetics of DNA load predict HPV 16 viral clearance. J Clin Virol (2011) 0.89
Characterization of the Human Cervical Mucous Proteome. Clin Proteomics (2010) 0.88
Lineages of oncogenic human papillomavirus types other than type 16 and 18 and risk for cervical intraepithelial neoplasia. J Natl Cancer Inst (2014) 0.87
Age-group differences in human papillomavirus types and cofactors for cervical intraepithelial neoplasia 3 among women referred to colposcopy. Cancer Epidemiol Biomarkers Prev (2011) 0.85
Epidemiologic modeling of cervical dysplasia with molecular and cytopathological markers. Gynecol Oncol (2007) 0.85
Psychosocial factors in risk of cervical intraepithelial lesions. J Womens Health (Larchmt) (2009) 0.78
Specificity of L1 peptides versus virus-like particles for detection of human papillomavirus-positive cervical lesions in females attending Engativa Hospital, Bogota, Colombia. J Clin Microbiol (2008) 0.77
Increased methylation of human papillomavirus type 16 DNA is associated with the severity of cervical lesions in infected females from northeast China. Oncol Lett (2017) 0.75
Lack of HPV 16 and 18 detection in serum of colposcopy clinic patients. J Clin Virol (2011) 0.75
Comparative analysis of HPV16 gene expression profiles in cervical and in oropharyngeal squamous cell carcinoma. Oncotarget (2017) 0.75
Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst (2004) 14.97
Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep (2007) 13.20
Prevalence of HPV infection among females in the United States. JAMA (2007) 10.55
Reduction in human papillomavirus (HPV) prevalence among young women following HPV vaccine introduction in the United States, National Health and Nutrition Examination Surveys, 2003-2010. J Infect Dis (2013) 6.04
Identification of ambiguities in the 1994 chronic fatigue syndrome research case definition and recommendations for resolution. BMC Health Serv Res (2003) 4.93
Alpha-fetoprotein, des-gamma carboxyprothrombin, and lectin-bound alpha-fetoprotein in early hepatocellular carcinoma. Gastroenterology (2009) 4.50
Human papillomavirus vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep (2014) 4.50
Prevalence and incidence of chronic fatigue syndrome in Wichita, Kansas. Arch Intern Med (2003) 4.46
Dose escalation of a curcuminoid formulation. BMC Complement Altern Med (2006) 3.59
Seroprevalence of human papillomavirus type 16 infection in the United States. J Infect Dis (2002) 3.42
Ovarian cancer biomarker performance in prostate, lung, colorectal, and ovarian cancer screening trial specimens. Cancer Prev Res (Phila) (2011) 3.33
A framework for evaluating biomarkers for early detection: validation of biomarker panels for ovarian cancer. Cancer Prev Res (Phila) (2011) 3.03
A compendium of potential biomarkers of pancreatic cancer. PLoS Med (2009) 3.00
Human papillomavirus infection and cervical cytology in women screened for cervical cancer in the United States, 2003-2005. Ann Intern Med (2008) 2.98
Chronic fatigue syndrome--a clinically empirical approach to its definition and study. BMC Med (2005) 2.97
Prevalence of genital human papillomavirus among females in the United States, the National Health And Nutrition Examination Survey, 2003-2006. J Infect Dis (2011) 2.88
Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the advisory committee on immunization practices. MMWR Morb Mortal Wkly Rep (2015) 2.73
The economic impact of chronic fatigue syndrome. Cost Eff Resour Alloc (2004) 2.47
Seroprevalence of human papillomavirus types 6, 11, 16, and 18 in the United States: National Health and Nutrition Examination Survey 2003-2004. J Infect Dis (2009) 2.43
SELDI-TOF MS whole serum proteomic profiling with IMAC surface does not reliably detect prostate cancer. Clin Chem (2007) 2.38
A prospective, multicenter, National Cancer Institute Early Detection Research Network study of [-2]proPSA: improving prostate cancer detection and correlating with cancer aggressiveness. Cancer Epidemiol Biomarkers Prev (2010) 2.36
The human proteome project: current state and future direction. Mol Cell Proteomics (2011) 2.34
Phase II trial of trastuzumab in women with advanced or recurrent, HER2-positive endometrial carcinoma: a Gynecologic Oncology Group study. Gynecol Oncol (2009) 2.32
Recruitment of minority and underserved populations in the United States: the Centers for Population Health and Health Disparities experience. Contemp Clin Trials (2008) 2.29
Markers for early detection of cancer: statistical guidelines for nested case-control studies. BMC Med Res Methodol (2002) 2.26
Analytical validation of serum proteomic profiling for diagnosis of prostate cancer: sources of sample bias. Clin Chem (2007) 2.23
Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study. BMJ (2006) 2.14
Flaxseed supplementation (not dietary fat restriction) reduces prostate cancer proliferation rates in men presurgery. Cancer Epidemiol Biomarkers Prev (2008) 1.99
A formal analysis of cytokine networks in chronic fatigue syndrome. Brain Behav Immun (2010) 1.95
Psychometric properties of the CDC Symptom Inventory for assessment of chronic fatigue syndrome. Popul Health Metr (2005) 1.94
Integrated weighted gene co-expression network analysis with an application to chronic fatigue syndrome. BMC Syst Biol (2008) 1.93
Pharmacokinetics of curcumin conjugate metabolites in healthy human subjects. Cancer Epidemiol Biomarkers Prev (2008) 1.85
A population-based study of the clinical course of chronic fatigue syndrome. Health Qual Life Outcomes (2003) 1.80
The effect of correct and consistent condom use on chlamydial and gonococcal infection among urban adolescents. Arch Pediatr Adolesc Med (2005) 1.78
Simultaneous amplification and identification of 25 human papillomavirus types with Templex technology. J Clin Microbiol (2006) 1.75
Effect of a low glycaemic index diet on blood glucose in women with gestational hyperglycaemia. Diabetes Res Clin Pract (2010) 1.71
Association of Chlamydia trachomatis with persistence of high-risk types of human papillomavirus in a cohort of female adolescents. Am J Epidemiol (2005) 1.67
Microsatellite instability and DNA mismatch repair protein deficiency in Lynch syndrome colorectal polyps. Cancer Prev Res (Phila) (2012) 1.65
Efficient DNA extraction for HPV genotyping in formalin-fixed, paraffin-embedded tissues. J Mol Diagn (2011) 1.64
Individual and geographic disparities in human papillomavirus types 16/18 in high-grade cervical lesions: Associations with race, ethnicity, and poverty. Cancer (2013) 1.64
Familial risk for common diseases in primary care: the Family Healthware Impact Trial. Am J Prev Med (2009) 1.62
Cervical cancer incidence in a prevaccine era in the United States, 1998-2002. Obstet Gynecol (2007) 1.60
Proteomics for cancer biomarker discovery. Clin Chem (2002) 1.57
Are chronic fatigue and chronic fatigue syndrome valid clinical entities across countries and health-care settings? Aust N Z J Psychiatry (2009) 1.57
Acceptance of the HPV vaccine among women, parents, community leaders, and healthcare providers in Ohio Appalachia. Vaccine (2009) 1.53
The word "cancer": how language can corrupt thought. BMJ (2013) 1.51
Effects of ginger supplementation on cell-cycle biomarkers in the normal-appearing colonic mucosa of patients at increased risk for colorectal cancer: results from a pilot, randomized, and controlled trial. Cancer Prev Res (Phila) (2013) 1.49
Overcoming challenges in designing and implementing a phase II randomized controlled trial using a presurgical model to test a dietary intervention in prostate cancer. Clin Trials (2008) 1.48
Chromoendoscopy detects more adenomas than colonoscopy using intensive inspection without dye spraying. Cancer Prev Res (Phila) (2008) 1.47
Orthostatic instability in a population-based study of chronic fatigue syndrome. Am J Med (2005) 1.47
Authors' self-declared financial conflicts of interest do not impact the results of major cardiovascular trials. J Am Coll Cardiol (2013) 1.47
Functional status of persons with chronic fatigue syndrome in the Wichita, Kansas, population. Health Qual Life Outcomes (2003) 1.46
Pharmacokinetics of 6-gingerol, 8-gingerol, 10-gingerol, and 6-shogaol and conjugate metabolites in healthy human subjects. Cancer Epidemiol Biomarkers Prev (2008) 1.45
Predictors of peritonitis in patients on peritoneal dialysis: results of a large, prospective Canadian database. Clin J Am Soc Nephrol (2009) 1.43
Recruitment and retention of economically underserved women to a cervical cancer prevention trial. Appl Nurs Res (2004) 1.41
Epidemiology of human papillomavirus infection and abnormal cytologic test results in an urban adolescent population. J Infect Dis (2003) 1.39
The health and housing in transition study: a longitudinal study of the health of homeless and vulnerably housed adults in three Canadian cities. Int J Public Health (2011) 1.39
Challenges for biomarkers in cancer detection. Ann N Y Acad Sci (2004) 1.38
Clinical utility of family history for cancer screening and referral in primary care: a report from the Family Healthware Impact Trial. Genet Med (2011) 1.38
Early adverse experience and risk for chronic fatigue syndrome: results from a population-based study. Arch Gen Psychiatry (2006) 1.31
Pancreatic cancer serum detection using a lectin/glyco-antibody array method. J Proteome Res (2009) 1.30
Plasma glycoprotein profiling for colorectal cancer biomarker identification by lectin glycoarray and lectin blot. J Proteome Res (2008) 1.29
Adults' knowledge and behaviors related to human papillomavirus infection. J Am Board Fam Pract (2004) 1.27
Prevalence of human papillomavirus types in invasive vulvar cancers and vulvar intraepithelial neoplasia 3 in the United States before vaccine introduction. J Low Genit Tract Dis (2012) 1.26
Posttranslational protein modifications: current implications for cancer detection, prevention, and therapeutics. Mol Cell Proteomics (2006) 1.24
Comparison of risk perceptions and beliefs across common chronic diseases. Prev Med (2008) 1.24
Post-licensure monitoring of HPV vaccine in the United States. Vaccine (2010) 1.24
Recent advances in biomarkers for cancer diagnosis and treatment. Drug Discov Today (2005) 1.23
Human papillomavirus infection and cytologic abnormalities of the anus and cervix among HIV-infected women in the study to understand the natural history of HIV/AIDS in the era of effective therapy (the SUN study). Sex Transm Dis (2011) 1.21
Results of the prospective multicenter trial of robotically assisted totally endoscopic coronary artery bypass grafting. Ann Thorac Surg (2006) 1.21
Towards Clinical Application of Methylated DNA Sequences as Cancer Biomarkers: A Joint NCI's EDRN and NIST Workshop on Standards, Methods, Assays, Reagents and Tools. Cancer Res (2007) 1.21
Utility of the blood for gene expression profiling and biomarker discovery in chronic fatigue syndrome. Dis Markers (2002) 1.20
Acyclovir-resistant genital herpes among persons attending sexually transmitted disease and human immunodeficiency virus clinics. Arch Intern Med (2003) 1.20
Inclusion of the glucocorticoid receptor in a hypothalamic pituitary adrenal axis model reveals bistability. Theor Biol Med Model (2007) 1.18
A real-time PCR assay for HPV52 detection and viral load quantification. Clin Lab (2012) 1.18
Serum protein expression profiling for cancer detection: validation of a SELDI-based approach for prostate cancer. Dis Markers (2004) 1.18
Age-appropriate use of human papillomavirus vaccines in the U.S. Gynecol Oncol (2009) 1.16
Mitochondrial genome deletion aids in the identification of false- and true-negative prostate needle core biopsy specimens. Am J Clin Pathol (2008) 1.15
Chronic fatigue syndrome and other fatiguing illnesses in adolescents: a population-based study. J Adolesc Health (2004) 1.15
DNA and RNA references for qRT-PCR assays in exfoliated cervical cells. J Mol Diagn (2006) 1.15
Biomarkers for prostate cancer detection. J Urol (2007) 1.14
Mass spectrometric assay for analysis of haptoglobin fucosylation in pancreatic cancer. J Proteome Res (2011) 1.14
Primary and secondary prevention of cervical cancer--opportunities and challenges. J Natl Cancer Inst (2009) 1.13
Population impact of HPV vaccines: summary of early evidence. J Adolesc Health (2013) 1.12
Family history and perceptions about risk and prevention for chronic diseases in primary care: a report from the family healthware impact trial. Genet Med (2010) 1.12